Vicarious Surgical (RBOT) Revenue & Revenue Breakdown
Vicarious Surgical Revenue Highlights
00
Vicarious Surgical Revenue by Period
Vicarious Surgical Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Vicarious Surgical Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $3.45M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Vicarious Surgical Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CNMD | CONMED | $1.24B | $316.70M |
BVS | Bioventus | $512.35M | $138.96M |
NVRO | Nevro | $425.17M | $104.16M |
FNA | Paragon 28 | $216.39M | $61.02M |
CTKB | Cytek Biosciences | $193.01M | $51.50M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SIBN | SI-BONE | $138.89M | $40.34M |
RXST | RxSight | $89.08M | $45.41M |
SGHT | Sight Sciences | $81.06M | $20.16M |
LUNG | Pulmonx | $68.67M | $20.39M |
NPCE | NeuroPace | $65.42M | $21.06M |
MXCT | MaxCyte | $41.29M | $8.16M |
CVRX | CVRx | $39.30M | $13.37M |
PROF | Profound Medical | $7.33M | $1.90M |
OFIX | Orthofix Medical | $100.00K | $198.62M |
RBOT | Vicarious Surgical | - | - |